San Francisco -- AliveCor, the San Francisco-based developer of a mobile electrocardiogram (ECG) device, said on Monday it has raised $10.5 million in its second round of funding, co-led by previous backer Burrill & Company and new investor Khosla Ventures. Other previous backers Qualcomm and the Oklahoma Life Sciences Fund also participated in the round, which the company will use to launch and commercialize its mobile ECG device, pending clearance by the Food and Drug Administration (FDA). "This funding provides us with the resources to support the global launch of our highly anticipated iOS and Android ECG devices, and to utilize our transformative technology and data to strategically build future devices and services," said Judy Wade, the company's president and CEO. AliveCor's mobile ECG device is designed to work in conjunction with a variety of mobile platforms, including iPhone, iPad and Android devices. The company has now raised $13.5 million since its inception.